137 related articles for article (PubMed ID: 38645474)
1. Testing a candidate composite serum protein marker of skin severity in systemic sclerosis.
Roblin E; Clark KEN; Beesley C; Ong VH; Denton CP
Rheumatol Adv Pract; 2024; 8(2):rkae039. PubMed ID: 38645474
[TBL] [Abstract][Full Text] [Related]
2. COMP: a candidate molecule in the pathogenesis of systemic sclerosis with a potential as a disease marker.
Hesselstrand R; Kassner A; Heinegård D; Saxne T
Ann Rheum Dis; 2008 Sep; 67(9):1242-8. PubMed ID: 18065498
[TBL] [Abstract][Full Text] [Related]
3. Integrated analysis of dermal blister fluid proteomics and genome-wide skin gene expression in systemic sclerosis: an observational study.
Clark KEN; Csomor E; Campochiaro C; Galwey N; Nevin K; Morse MA; Teo YV; Freudenberg J; Ong VH; Derrett-Smith E; Wisniacki N; Flint SM; Denton CP
Lancet Rheumatol; 2022 Jul; 4(7):e507-e516. PubMed ID: 36404995
[TBL] [Abstract][Full Text] [Related]
4. Cartilage Oligomeric Matrix Protein (COMP) in systemic sclerosis (SSc): role in disease severity and subclinical rheumatoid arthritis overlap.
Gheita TA; Hussein H
Joint Bone Spine; 2012 Jan; 79(1):51-6. PubMed ID: 21497537
[TBL] [Abstract][Full Text] [Related]
5. High-throughput quantitative histology in systemic sclerosis skin disease using computer vision.
Correia C; Mawe S; Lofgren S; Marangoni RG; Lee J; Saber R; Aren K; Cheng M; Teaw S; Hoffmann A; Goldberg I; Cowper SE; Khatri P; Hinchcliff M; Mahoney JM
Arthritis Res Ther; 2020 Mar; 22(1):48. PubMed ID: 32171325
[TBL] [Abstract][Full Text] [Related]
6. Cartilage oligomeric matrix protein expression in systemic sclerosis reveals heterogeneity of dermal fibroblast responses to transforming growth factor beta.
Farina G; Lemaire R; Pancari P; Bayle J; Widom RL; Lafyatis R
Ann Rheum Dis; 2009 Mar; 68(3):435-41. PubMed ID: 18408251
[TBL] [Abstract][Full Text] [Related]
7. High burden of skin sclerosis is associated with severe organ involvement in patients with systemic sclerosis and systemic sclerosis overlap syndrome.
Wannarong T; Muangchan C
Rheumatol Int; 2018 Dec; 38(12):2279-2288. PubMed ID: 30206672
[TBL] [Abstract][Full Text] [Related]
8. A four-gene biomarker predicts skin disease in patients with diffuse cutaneous systemic sclerosis.
Farina G; Lafyatis D; Lemaire R; Lafyatis R
Arthritis Rheum; 2010 Feb; 62(2):580-8. PubMed ID: 20112379
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor 9 in systemic sclerosis patients: relation to modified Rodnan skin score, disease severity, and functional status.
Gheita TA; Sayed S; Azkalany GS; Abaza N; Hammam N; Eissa AH
Clin Rheumatol; 2018 Mar; 37(3):757-763. PubMed ID: 29076114
[TBL] [Abstract][Full Text] [Related]
10. Recurrence of progressive skin involvement following discontinuation or dose reduction of Mycophenolate Mofetil treatment in patients with diffuse Systemic Sclerosis.
Mendoza FA; Lee-Ching C; Jimenez SA
Semin Arthritis Rheum; 2020 Feb; 50(1):135-139. PubMed ID: 31311679
[TBL] [Abstract][Full Text] [Related]
11. Skin improvement is a surrogate for favourable changes in other organ systems in early diffuse cutaneous systemic sclerosis.
Nevskaya T; Zheng B; Baxter CA; Ramey DR; Pope JE; Baron M;
Rheumatology (Oxford); 2020 Jul; 59(7):1715-1724. PubMed ID: 31774531
[TBL] [Abstract][Full Text] [Related]
12. Increased serum COMP predicts mortality in SSc: results from a longitudinal study of interstitial lung disease.
Hesselstrand R; Andréasson K; Wuttge DM; Bozovic G; Scheja A; Saxne T
Rheumatology (Oxford); 2012 May; 51(5):915-20. PubMed ID: 22253028
[TBL] [Abstract][Full Text] [Related]
13. Circulating Collagen Metabolites and the Enhanced Liver Fibrosis (ELF) Score as Fibrosis Markers in Systemic Sclerosis.
Chen C; Wang L; Wu J; Lu M; Yang S; Ye W; Guan M; Liang M; Zou H
Front Pharmacol; 2022; 13():805708. PubMed ID: 35177989
[No Abstract] [Full Text] [Related]
14. Evaluation of Scleroderma Clinical Trials Consortium training recommendations on modified Rodnan skin score assessment in scleroderma.
Low AHL; Ng SA; Berrocal V; Brennan B; Chan G; Ng SC; Khanna D
Int J Rheum Dis; 2019 Jun; 22(6):1036-1040. PubMed ID: 30838791
[TBL] [Abstract][Full Text] [Related]
15. Prediction of worsening of skin fibrosis in patients with diffuse cutaneous systemic sclerosis using the EUSTAR database.
Maurer B; Graf N; Michel BA; Müller-Ladner U; Czirják L; Denton CP; Tyndall A; Metzig C; Lanius V; Khanna D; Distler O;
Ann Rheum Dis; 2015 Jun; 74(6):1124-31. PubMed ID: 24981642
[TBL] [Abstract][Full Text] [Related]
16. Nintedanib in Patients With Systemic Sclerosis-Associated Interstitial Lung Disease: Subgroup Analyses by Autoantibody Status and Modified Rodnan Skin Thickness Score.
Kuwana M; Allanore Y; Denton CP; Distler JHW; Steen V; Khanna D; Matucci-Cerinic M; Mayes MD; Volkmann ER; Miede C; Gahlemann M; Quaresma M; Alves M; Distler O
Arthritis Rheumatol; 2022 Mar; 74(3):518-526. PubMed ID: 34514739
[TBL] [Abstract][Full Text] [Related]
17. Minimal Clinically Important Differences for the Modified Rodnan Skin Score: Results from the Scleroderma Lung Studies (SLS-I and SLS-II).
Khanna D; Clements PJ; Volkmann ER; Wilhalme H; Tseng CH; Furst DE; Roth MD; Distler O; Tashkin DP
Arthritis Res Ther; 2019 Jan; 21(1):23. PubMed ID: 30651141
[TBL] [Abstract][Full Text] [Related]
18. A longitudinal biomarker for the extent of skin disease in patients with diffuse cutaneous systemic sclerosis.
Rice LM; Ziemek J; Stratton EA; McLaughlin SR; Padilla CM; Mathes AL; Christmann RB; Stifano G; Browning JL; Whitfield ML; Spiera RF; Gordon JK; Simms RW; Zhang Y; Lafyatis R
Arthritis Rheumatol; 2015 Nov; 67(11):3004-15. PubMed ID: 26240058
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of limited hand mobility in systemic sclerosis patients by using "prayer sign" and "tabletop sign".
Uslu S; Gülle S; Can G; Sarı İ; Önen F; Birlik M
Clin Rheumatol; 2021 Jul; 40(7):2771-2777. PubMed ID: 33555460
[TBL] [Abstract][Full Text] [Related]
20. Brief report: lysyl oxidase is a potential biomarker of fibrosis in systemic sclerosis.
Rimar D; Rosner I; Nov Y; Slobodin G; Rozenbaum M; Halasz K; Haj T; Jiries N; Kaly L; Boulman N; Daood R; Vadasz Z
Arthritis Rheumatol; 2014 Mar; 66(3):726-30. PubMed ID: 24574233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
